Peptide Hubs
Tirzep 5 mg
90.00 USD
Tirzep 5 mg – Dual GIP/GLP-1 Peptide for Metabolic Research
Active Ingredient: Tirzepatide
Manufacturer: Peptide Hubs
Pack Size: 2 mL Vial
Shipping From:
International
Tirzep 5 mg Detailed
WHAT IS TIRZEP 5 MG?
Tirzepatide 5 mg is a dual agonist peptide that activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. This makes it a highly promising compound in ongoing studies related to weight loss, glycemic control, and metabolic disorders. Tirzepatide is known to support enhanced insulin sensitivity and appetite regulation.
RESEARCH APPLICATIONS
- Appetite suppression and satiety enhancement
- Improved glucose regulation in metabolic research
- Supports body weight and fat mass reduction studies
- Potential synergy with other peptides like Cagrilintide
MECHANISM OF ACTION
Tirzepatide mimics the actions of both GIP and GLP-1, stimulating insulin release, reducing glucagon levels, and slowing gastric emptying. This dual mechanism improves energy balance and may reduce body weight in clinical research models.
RECOMMENDED USE IN RESEARCH
- Dosage: 2.5–10 mg weekly, depending on the study design
- Route: Subcutaneous injection
- Cycle: 8–16 weeks in long-term metabolic research
STACKING OPTIONS
Popular peptides often stacked with Tirzepatide include:
- Mazdutide – Dual GIP/GLP-1 analog for glucose studies
- Survodutide – Glucagon-based dual agonist
- Semaglutide – GLP-1 receptor-specific support
BUY TIRZEP ONLINE
Order Tirzepatide 5 mg online from a trusted peptide supplier. Peptide Hubs ensures high-purity compounds suitable for laboratory research. Ships within the USA from domestic stock.
EXTERNAL LINK
For detailed chemical data, refer to the Tirzepatide entry on PubChem.
FAQ
What is Tirzepatide used for in research?
It's studied for its effects on weight management, glycemic control, and satiety in subjects with metabolic disorders.
How does Tirzepatide compare to Semaglutide?
While Semaglutide targets only GLP-1 receptors, Tirzepatide targets both GIP and GLP-1, potentially offering broader metabolic benefits.
Can Tirzepatide be combined with Cagrilintide?
Yes. Studies indicate that this combination may provide enhanced appetite suppression and weight control synergy.
What is the ideal dose in research settings?
Typical research begins at 2.5 mg and increases to 5–10 mg weekly, adjusted based on observed outcomes.
Is Tirzepatide intended for human consumption?
No. Tirzepatide 5 mg is sold strictly for laboratory and research purposes only. Not for human use.
No reviews found
Please log in to write Tirzep 5 mg review.
Related Offers
US Domestic & International
Kalpa Pharmaceuticals LTD, India
Tirzexyl 5 mg – Advanced Support for Fat Loss & Glucose Control
Active Ingredient: Tirzepatide
Manufacturer: Kalpa Pharmaceuticals
Pack Size: 2 mL Vial (5 mg/vial)
90.00 USD
Lab Tested
US Domestic & International
Dragon Pharma, Europe
Tirze-Pep 5 mg – Dual GIP/GLP-1 Support for Weight Control
Active Ingredient: Tirzepatide
Manufacturer: Dragon Pharma
Pack Size: 2 mL Vial (5 mg/vial)
Lab Report: View Results
90.00 USD
Lab Tested
US Domestic & International
Stealth Labs
Tirzep 20 mg – Dual GIP/GLP-1 Receptor Agonist for Fat Loss
Active Ingredient: Tirzepatide
Manufacturer: Stealth Labs
Pack Size: 2 mL Vial (20 mg/vial)
Note: Ships without label for added privacy.
Lab Report: View Results
175.00 USD
International
Simplex Novonordisk, Turkey
Norditropin 45 IU – Advanced HGH Therapy in Cartridge Form
Active Ingredient: Human Growth Hormone (Somatropin)
Manufacturer: Novo Nordisk
Pack Size: 1 Cartridge (45 IU total)
330.00 USD
International
NovoNordisk, Turkey
Peptide Hormone
Raw Material: Insulin Aspart
Manufacturer: Novo Nordisk
Package: 5 Pens x 3 mL [100 IU/mL]
90.00 USD